Join our community of smart investors

Impellam's global play proves well timed

The recruitment consultancy delivered on its international expansion
March 13, 2017

Organisations generally tend to avoid handing out employment contracts when the economy is in a state of uncertainty. The Brexit vote, coupled with candidate shortages in education and NHS pay rate caps, meant that the odds were firmly against Impellam (IPEL) in 2016.

IC TIP: Buy at 764p

Fortunately, acquisitions made the previous year helped the UK's second-largest staffing business by revenue to find recruitment opportunities elsewhere. With Michigan-based Bartech and healthcare specialist Global Group on board, Impellam ended the year registering a surge in top-line growth and a 21 per cent rise in adjusted cash profit to £70.1m.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in